| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 346.752 | 89 |
| GSM780708 | Untreated after 4 days (C2_1) | 359.403 | 89 |
| GSM780709 | Untreated after 4 days (C3_1) | 409.655 | 90 |
| GSM780719 | Untreated after 4 days (C1_2) | 348.294 | 89 |
| GSM780720 | Untreated after 4 days (C2_2) | 387.477 | 90 |
| GSM780721 | Untreated after 4 days (C3_2) | 429.97 | 90 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 351.799 | 89 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 310.096 | 88 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 312.919 | 88 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 382.887 | 89 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 343.29 | 89 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 327.118 | 88 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 294.992 | 87 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 366.716 | 89 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 346.438 | 89 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 324.038 | 88 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 361.516 | 89 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 338.107 | 88 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 344.146 | 89 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 334.719 | 88 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 347.941 | 89 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 349.96 | 89 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 392.844 | 90 |